Literature DB >> 17089792

Modern evolutionary history of the human KSHV genome.

G S Hayward1, J C Zong.   

Abstract

The genomes of several human herpesviruses, including Kaposi sarcoma (KS) herpesvirus (KSHV), display surprisingly high levels of both genetic diversity and clustered subtyping at certain loci. We have been interested in understanding this phenomenon with the hope that it might be a useful diagnostic tool for viral epidemiology, and that it might provide some insights about how these large viral genomes evolve over a relatively short timescale. To do so, we have carried out extensive PCR DNA sequence analysis across the genomes of 200 distinct KSHV samples collected from KS patients around the world. Here we review and summarize current understanding of the origins of KSHV variability, the spread of KSHV and its human hosts out of Africa, the existence of chimeric genomes, and the concept that different segments of the genome have had different evolutionary histories.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17089792     DOI: 10.1007/978-3-540-34344-8_1

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  32 in total

1.  Whole-Genome Sequencing of Kaposi's Sarcoma-Associated Herpesvirus from Zambian Kaposi's Sarcoma Biopsy Specimens Reveals Unique Viral Diversity.

Authors:  Landon N Olp; Adrien Jeanniard; Clemence Marimo; John T West; Charles Wood
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

Review 2.  Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication.

Authors:  Emily Cousins; John Nicholas
Journal:  Recent Results Cancer Res       Date:  2014

3.  Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.

Authors:  Bizunesh Abere; Naira Samarina; Silvia Gramolelli; Jessica Rückert; Gisa Gerold; Andreas Pich; Thomas F Schulz
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

4.  Human herpesvirus 8 DNA detection and variant analysis in patients with multiple sclerosis.

Authors:  Sayed Mahdi Marashi; Aliehossadat Mostafa; Zabihollah Shoja; Ahmad Nejati; Shohreh Shahmahmoodi; Yaghoub Mollaei-Kandelous; Mohammad Ali Sahraian; Somayeh Jalilvand
Journal:  Virusdisease       Date:  2018-08-10

5.  Early childhood infection of Kaposi's sarcoma-associated herpesvirus in Zambian households: a molecular analysis.

Authors:  Landon N Olp; Danielle M Shea; Maxine K White; Clement Gondwe; Chipepo Kankasa; Charles Wood
Journal:  Int J Cancer       Date:  2012-08-20       Impact factor: 7.396

Review 6.  Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  J Clin Invest       Date:  2016-09-01       Impact factor: 14.808

7.  Stage-stratified approach to AIDS-related Kaposi's sarcoma: implications for resource-limited environments.

Authors:  Susan E Krown; Margaret Z Borok; Thomas B Campbell; Corey Casper; Dirk P Dittmer; Mina C Hosseinipour; Ronald T Mitsuyasu; Anisa Mosam; Jackson Orem; Warren T Phipps
Journal:  J Clin Oncol       Date:  2014-07-07       Impact factor: 44.544

Review 8.  Reflections on the interpretation of heterogeneity and strain differences based on very limited PCR sequence data from Kaposi's sarcoma-associated herpesvirus genomes.

Authors:  Jian-Chao Zong; Ravit Arav-Boger; Donald J Alcendor; Gary S Hayward
Journal:  J Clin Virol       Date:  2007-08-14       Impact factor: 3.168

9.  Evaluation of global clustering patterns and strain variation over an extended ORF26 gene locus from Kaposi's sarcoma herpesvirus.

Authors:  Jian-Chao Zong; Henry Kajumbula; William Boto; Gary S Hayward
Journal:  J Clin Virol       Date:  2007-08-08       Impact factor: 3.168

Review 10.  Comparative pathobiology of Kaposi sarcoma-associated herpesvirus and related primate rhadinoviruses.

Authors:  Susan V Westmoreland; Keith G Mansfield
Journal:  Comp Med       Date:  2008-02       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.